Earnings Scheduled For March 2, 2022
Companies Reporting Before The Bell
• SIGNA Sports United (NYSE:SSU) is expected to report quarterly loss at $0.04 per share on revenue of $283.61 million.
BTIG Maintains Buy on OrthoPediatrics, Lowers Price Target to $68
BTIG analyst Ryan Zimmerman maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $75 to $68.
Truist Securities Maintains Buy on OrthoPediatrics, Lowers Price Target to $75
Truist Securities maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $78 to $75.
OrthoPediatrics Q3 EPS $(0.11) Beats $(0.28) Estimate, Sales $25.10M Miss $26.28M Estimate
OrthoPediatrics (NASDAQ:KIDS) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.28) by 60.71 percent. This is a 54.17 percent increase over losses of $(0.24) per share from
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell
• R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.
The Daily Biotech Pulse: Moderna Awaits Adcom Ruling On COVID-19 Booster Shot; Teligent Files For Chapter 11; CFO Transitions at Catalyst Biosciences, CRISPR; Lucid Diagnostics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours:
OrthoPediatrics, SeaSpine Ink Distribution Pact For Image Guidance System
OrthoPediatrics Corp (NASDAQ:KIDS) entered into a distribution agreement with SeaSpine Holdings Corporation (NASDAQ:SPNE) for the 7D Surgical FLASH Navigation platform. Under the 5-year…
OrthoPediatrics Announces Entry Into Distribution Agreement With SeaSpine To Exclusively Distribute The 7D Surgical FLASH Navigation Platform For Pediatric Applications
OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced they have entered into a
Orthopediatrics Insider Sold Over $357.50 Thousand In Company Stock
Fred Hite, Coo And Cfo at Orthopediatrics (NASDAQ:KIDS), made a large insider sell on September 2, according to a new SEC filing.
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 1)